Cellulite and extracorporeal Shockwave therapy (CelluShock-2009)--a randomized trial

Karsten Knobloch, Beatrice Joest, Peter M Vogt, Karsten Knobloch, Beatrice Joest, Peter M Vogt

Abstract

Background: Cellulite is a widespread problem involving females' buttocks and thighs based on the female specific anatomy. Given the higher number of fat cells stored in female fatty tissue in contrast to males, and the aging process of connective tissue leads to an imbalance between lipogenesis and lipolysis with subsequent large fat cells bulging the skin. In addition, microcirculatory changes have been suggested, however remain largely unknown in a controlled clinical setting. We hypothesize that the combination of extracorporeal shockwave and a daily gluteal muscle strength program is superior to the gluteal muscle strength program alone in cellulite.

Study design: Randomized-controlled trial. IRB approval was granted at Hannover Medical School, Germany on May 22, 2009. For allocation of participants, a 1:1 ratio randomization was performed using opaque envelopes for the concealment of allocation. Reporting: according to CONSORT 2010. Eligible patients were females aged 18 or over and 65 or younger with cellulite with documented cellulite 1°-4° according to the Nürnberger score. Exclusion criteria were suspected or evident pregnancy, no cellulite, no informed consent or age under 18 years or above 65 years. Patients were recruited by advertisements in local regional newspapers and via the Internet.

Analysis: Intention-to-treat.

Outcome parameters: a) Photonumeric severity scale, b) Nürnberger Score, c) circumference measurements, d) capillary blood flow, e) tissue oxygen saturation, f) postcapillary venous blood flow. Intervention group: Six sessions of extracorporeal focused shock wave for six sessions (2000 impulses, 0,25 mJ/m2 every 1-2 weeks) at both gluteal and thigh regions plus a specific gluteal strength exercise training.

Control group: Six sessions of sham extracorporeal focused shock wave for six sessions (2000 impulses, 0,01 mJ/m2 every 1-2 weeks) at both gluteal and thigh regions plus a specific gluteal strength exercise training.

Follow-up: 12 weeks. Blinding was achieved for all participants enrolled in the trial, the photograph taking the digital images for the primary outcome measure, the two assessors of the outcome measures, all additional health care providers and for the analyst from the biometrical department. Only one researcher (BJ) was aware of the group assignment performing the randomisation and the extracorporeal shock wave therapy.

Discussion: This randomised-controlled trial will provide much needed evidence on the clinical effectiveness of focused extracorporal shock wave therapy as an adjunct to gluteal strength training in females suffering cellulite.

Trial registration: ClinicalTrials.gov NCT00947414.

Figures

Figure 1
Figure 1
CONSORT patient flow chart.
Figure 2
Figure 2
First exercise (15 repetitions per leg twice a day over 12 weeks).
Figure 3
Figure 3
First exercise (15 repetitions per leg twice a day over 12 weeks).
Figure 4
Figure 4
Second exercise (15 repetitions per leg twice a day over 12 weeks).
Figure 5
Figure 5
Second exercise (15 repetitions per leg twice a day over 12 weeks).

References

    1. Godlee F. Publishing study protocols: making them visible will improve registration, reporting and recruitment. BMC News and Views. 2001;2:4.
    1. Christ C, Brenke G, Sattler G. et al.Steigerung der Hautelastizität und Revitalisierung der Dermis bei Cellulite und Bindegewebsschwäche durch die extrakorpoale Acoustic Wave Therapy (AWT) Ästhetische Dermatologie. 2008;1:2–10.
    1. Sattler G, Pohl U, Raegener K. Pilotstudie akustische Wellentherapie (AWT) bei Cellulite. Äathetische Dermatologie. 2008;2:16–25.
    1. Angehrn F, Kuhn C, Voss A. Can cellulite be treated with low-energy extracorporal shock wave therapy? Clin Interv Aging. 2007;2(4):623–30.
    1. Kuhn C, Angehrn F, Sonnabend O, Voss A. Impact of extracorporal shock waves on the human skin with cellulite: a case study of an unique instance. Clin Interv Aging. 2008;3(1):201–10.
    1. Christ C, Brenke R, Sattler G, Siems W, Novak P, Daser A. Improvement in skin elasticity in the treatment of cellulite and connective tissue wekness by means of extracorporal pulse activation therapy. Aesthet Surg. 2008;28(5):538–44. doi: 10.1016/j.asj.2008.07.011.
    1. Adatto M, Adatto-Neilson R, Servant JJ, Vester J, Novak P, Krotz A. Controlled, randomized study evaluating the effects of treating cellulite with AWT®/EPAT®. J Cosmet Laser Ther. 2010;12:176–182. doi: 10.3109/14764172.2010.500392.
    1. Schulz KF, Altman DG, Moher D. for the CONSORT group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Medicine. 2010;8:18. doi: 10.1186/1741-7015-8-18.
    1. Schulz KF, Altman DG, Moher D, Fergusson D. CONSORT 2010 changes and testing blindness in RCTs. Lancet. 2010;375(9721):1144–6. doi: 10.1016/S0140-6736(10)60413-8.
    1. Weiss NS, Koepsell TD, Psaty BM. Generalizability of the results of randomized trials. Arch Intern Med. 2008;168:133–5. doi: 10.1001/archinternmed.2007.30.
    1. Rothwell PM. External validity of ranodmised controlled trials: „to whom do the results of this trial apply?". Lancet. 2005;365:82–93. doi: 10.1016/S0140-6736(04)17670-8.
    1. Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297(11):1233–40. doi: 10.1001/jama.297.11.1233.
    1. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? BMJ. 2008;336:1472–4. doi: 10.1136/bmj.39590.732037.47.
    1. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148:295–309.
    1. Hexsel DM, Dal'Forno TD, Hexsel CL. A validated photonumeric cellulite severity scale. J Eur Acad Dermatol Venereol. 2009;23(5):523–8. doi: 10.1111/j.1468-3083.2009.03101.x.
    1. Nürnberger F, Müller G. So-called cellulite: An invented disease. J Dermatol Surg Oncol. 1978;4:221–9.
    1. Lautenschläger H. Skin diagnosis - based on measuring results. Kosmetik International. 2008;10:54–56.
    1. Lautenschläger H. Skin analysis - customer interview to complement measurements. Kosmetik International. 2004;8:72–4.
    1. Lautenschläger H. Skin analysis - with the support of modern instruments. Kosmetik International. 2003;3:102–4.
    1. Lautenschläger H. Instruments for skin analysis. Kostmetik International. 2001;1:90.
    1. Knobloch K, Lichtenberg A, Pichlmaier M, Tomaszek S, Krug A, Haverich A. Palmar microcirculation after harvesting of the radial artery in coronary revascularisation. Ann Thorac Surg. 2005;79(3):1026–30. doi: 10.1016/j.athoracsur.2004.03.026.
    1. Knobloch K, Kraemer R, Lichtenberg A, Jagodzinski M, Gossling T, Richter M, Zeichen J, Hufner T, Krettek C. Achilles tendon and paratendon microcirculation in midportion and insertional tendinopathy in athletes. Am J Sports Med. 2006;34(1):92–7. doi: 10.1177/0363546505278705.
    1. Reenalda J, Van Geffen P, Nederhand M, Jannink M, Ijzerman M, Rietman H. Analysis of healthy sitting behaviour: interface pressure distribution and subcutaneous tissue oxygenation. J Rehabil Res Dev. 2009;46(5):577–86. doi: 10.1682/JRRD.2008.12.0164.
    1. Knobloch K, Lichtenberg A, Pichlmaier M, Mertsching H, Krug A, Klima U, Haverich A. Microcirculation of the sternum following harvesting of the left internal mammary artery. Thorac Cardiovasc Surg. 2003;51(5):255–9. doi: 10.1055/s-2003-43083.
    1. Kraemer R, Lorenzen J, Rotter R, Vogt PM, Knobloch K. Achilles tendon suture deteriorates tendon capillary blood flow with sustained tissue oxygen saturation - an animal study. J Orthop Surg Res. 2009;4:32. doi: 10.1186/1749-799X-4-32.
    1. Knobloch K, Grasemann R, Spies M, Vogt PM. Midportion Achilles tendon microcirculation after intermittent combined cryotherapy and compression compared with cryotherapy alone: a randomized trial. Am J Sports Med. 2008;36(11):2128–38. doi: 10.1177/0363546508319313.
    1. Altman DG, Schulz KF. Statistics notes: concealing treatment allocation in randomised trials. BMJ. 2001;323:446–7. doi: 10.1136/bmj.323.7310.446.
    1. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA. 1994;272:125–8. doi: 10.1001/jama.272.2.125.
    1. Sackett DL. Turning a blind eye: why we don't test for blindness at the end of our trials. BMJ. 2004;328:1136. doi: 10.1136/bmj.328.7448.1136-a.

Source: PubMed

3
S'abonner